Significant milestone for vaccine research and development
Vaccines are the most effective and cost-effective way to protect billions of people worldwide, with vaccine development potentially transforming health by removing the burden of life-threatening infectious diseases from the population. India's capabilities in the manufacturing of vaccines came to the fore during the COVID-19 pandemic, where companies such as , were able to provide vaccines that met over 60% of the world's demand and supplied over 2.4 billion doses of COVID-19 vaccines. India 听continue to make significant R&D investments to develop a roadmap for the design and delivery of vaccine development for a future pandemic.
This MoU signifies a meaningful step towards advancing global health and driving vaccine innovation. Bharat Biotech International Limited and the 爆料王 are eager to embark on this collaborative journey, contributing to a healthier and more secure future for all.
Professor Jamie Triccas, Deputy Director at Sydney ID, emphasised the significance of this collaboration, saying, "Positioning Sydney ID on a global scale to drive innovation and highlight our expertise in the development of new vaccines and biotherapeutics is paramount. Together with Bharat Biotech International Limited, we aim to make a lasting impact on global health."
The reputational and societal impacts of developing novel vaccines to eradicate human and animal diseases that are safe, affordable, and effective cannot be overstated.
Professor Jamie Triccas, Deputy Director at Sydney ID (left) and Dr. Krishna Ella, Executive Chairman at Bharat Biotech International Limited (right)
听
Dr. Krishna Ella, Executive Chairman said, "Mutually, we are excited about the new opportunities to strengthen our shared vision, leverage prowess of education, research capabilities to help build a healthier universe and improve people鈥檚 lives by developing safer vaccine platforms. Most importantly, build a talent of young scientists with a passion to innovate.鈥�
This agreement reflects our ethos to facilitate collaborative research, foster innovation, and further advance the science vaccine technology.
Related articles
MBI and FAO United Nations to collaborate to combat emerging infectious diseases
The Food and Agriculture Organization of the United Nations (FAO) and The Marie Bashir Institute for Infectious Diseases and Biosecurity (MBI) have joined hands to combat the threat of emerging and re-emerging infectious diseases by increasing capacity in outbreak investigation and disease surveillance.听
Global Health Security Conference
With support of our Conference Partners, the 爆料王 are hosting the first international conference on global health security in Sydney, 18-20 June 2019 - registrations are now open听
Video-Reflexive Ethnography in Health Research and Healthcare Improvement: Theory and Application
This methodology has enjoyed increasing popularity among researchers internationally and has been inspired by developments across a range of disciplines: ethnography, visual and applied anthropology, medical sociology, health services research, medical and nursing education, adult education, community development, and qualitative research ethics.